KIARO AI Readiness intelligence

Built for human-accountable review

AI-assisted readiness intelligence for pharma material review

Kiaro helps medical, regulatory, compliance and copy approval teams find evidence gaps, readiness risks and recurring review issues before final human sign-off.

Request pilot access See how Kiaro works

Decision support, not automatic approval. Authorised reviewers remain accountable for final assessment and sign-off.

Illustrative product view · No customer data
KIARO AI
Human sign-off required
Promotional material · page 2 of 6 Annotated view
HCP EDUCATIONAL MATERIAL

Supporting confident treatment conversations

A concise overview of evidence, appropriate patient context and safety information.

Clinical evidence supports a meaningful improvement in outcomes for eligible patients when assessed in the context of the authorised indication.

1
EvidencePrimary endpoint summary
ContextPopulation and limitations

Prescribing decisions should consider the full Summary of Product Characteristics, including current safety and monitoring information.

2
Reference 1Prescribing information
Human final sign-off remains required
Designed for pharma promotional review
Source-aware findings and evidence checks
Annotated outputs and structured records
Governance and audit support

From material to recurring intelligence

A review workflow that keeps evidence, findings and human decisions connected.

Kiaro brings source context and targeted quality checks into one traceable readiness process.

  1. 01Upload material and context

    Add the document, reference pack and review context.

  2. 02Extract document content

    Resolve text and structure across pages or slides.

  3. 03Retrieve source context

    Bring relevant references into the review scope.

  4. 04Perform AI-assisted review

    Surface potential readiness and compliance risks.

  5. 05Apply targeted checks

    Strengthen claim, safety and reference scrutiny.

  6. 06Resolve finding locations

    Connect each finding to the relevant document area.

  7. 07Generate review outputs

    Create annotated material and a structured register.

  8. 08Identify recurring themes

    Turn repeated findings into process intelligence.

Core capabilities

Practical readiness support across the review lifecycle.

Built around the artefacts and questions review teams already work with—not a separate black-box approval process.

01 · REVIEW

Promotional material readiness review

Helps teams triage potential issues before authorised reviewers make the final decision.

02 · EVIDENCE

Claim and evidence-gap detection

Surfaces claims that may be unsupported, weakly substantiated or missing usable references.

03 · ALIGNMENT

ABPI, SmPC, PI and safety checks

Supports focused assessment against supplied codes, product information and safety context.

04 · OUTPUTS

Annotated PDF and presentation outputs

Places clear, numbered findings near the relevant page or slide location for reviewer use.

05 · TRACEABILITY

Review registers and audit support

Creates structured records that support follow-up, governance conversations and auditability.

06 · COMPANION

Human reviewer companion chat

Supports scoped conversations about claims, references, guidance and surfaced findings.

07 · INTELLIGENCE

Quarterly readiness and governance intelligence

Aggregates recurring review themes into leadership-ready insight and recommended areas for process improvement.

Explore intelligence

Quarterly readiness intelligence

See where review pressure is recurring—not just where the last finding appeared.

Kiaro can turn aggregated pilot activity into a periodic intelligence view for medical, regulatory, compliance and operational leaders.

  • Review volumes and trends
  • Recurring risk themes
  • Unsupported claims
  • SmPC / PI alignment
  • Safety and adverse-event wording
  • Reference-pack completeness
  • Blocker findings
  • Human review signals
  • Chat usefulness
  • Recommended next actions

Readiness intelligence, not certification. Reports support process insight and governance; they do not certify compliance or replace professional review.

KIARO AIQuarterly readiness insights
Illustrative quarter Human final sign-off required
EXECUTIVE SIGNAL Review activity is stable, with repeat risks concentrated in claim support and source-pack currency.

Use recurring signals to focus the next review period.

Reviews42Volume signal
Findings684Theme visibility
Reference coverage91%Pack completeness
Chat usefulness82%Human signal
Review volume and findingsIllustrative
Week 1Week 6Week 12
Recurring risk themesShare
SmPC / PI alignment34%
Unsupported claims29%
Safety / AE wording20%
Reference currency17%
Strengthen claim substantiation

Reinforce source expectations at material intake.

Improve version control

Confirm current SmPC / PI in every source pack.

Track reviewer signals

Use human feedback to refine focus areas.

Illustrative interface and data · No customer or live review information

Human accountability by design

Professional judgement stays at the centre of every review.

Kiaro supports professional review. It does not replace medical, regulatory or compliance judgement, and it does not approve or certify material automatically.

01

Final approval and sign-off remain with the customer’s authorised reviewers.

02

Findings should be assessed for the relevant product, market and intended audience.

03

Reviewers should consider current source materials, applicable codes and company procedures.

04

Kiaro helps surface potential issues; it does not guarantee compliance or eliminate risk.

A controlled path to value

Test Kiaro against a defined review workflow.

A focused pilot can help your team understand where AI-assisted readiness review adds practical value while preserving your governance and final sign-off process.

  • Faster first-pass triage for material entering review.
  • More consistent issue identification across reviewers and formats.
  • Clearer evidence and reference gaps before final assessment.
  • Better visibility of repeated problems across review activity.
  • More useful annotated outputs for focused reviewer follow-up.
  • Improved governance conversations across cross-functional teams.
REQUEST A PILOT CONVERSATION

Request pilot access

Tell us a little about your review environment. Please do not include patient data, confidential materials or review content.

Pilot requests are sent securely to Kiaro’s private business inbox. Please do not include patient data, confidential materials or review content.

Start with a focused conversation

Explore where readiness intelligence could support your review team.

Request pilot access